Investors Failed To Show IPO Statements Were Misleading, 3rd Circuit Finds
PHILADELPHIA — A panel of the Third Circuit U.S. Court of Appeals affirmed dismissal of an investor’s securities fraud class action against a medical device manufacturer, agreeing with the trial court...To view the full article, register now.
Already a subscriber? Click here to view full article